## Background: To enhance the specificity of psa in diagnosis of cancer, several approaches have been evaluated, having in common the study of fractions of psa. the aim of this study was to evaluate the usefulness of complexed psa in the differential diagnosis between benign prostate hyperplasia (b
Differentiation of prostate cancer and benign prostatic hyperplasia: the clinical value of201Tl SPECT—A pilot study
✍ Scribed by Ching-Chiang Yang; Shung-Shung Sun; Chun-Yi Lin; Feng-Ju Chuang; Chia-Hung Kao
- Publisher
- Springer Japan
- Year
- 2003
- Tongue
- English
- Weight
- 726 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0914-7187
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In benign hyperplasia marked beta-glucuronidase and N-acetyl-beta-glucosaminidase activity was seen in the prostatic epithelium whereas the reactions for 5 other glycosidases were only slight or negative. The intensity of the reaction for the glycosidases in prostatic carcinoma was dependent upon th
## Abstract Because androgens likely play a key role in prostate growth and prostate cancer development, variants of genes involved in androgen biosynthesis may be related to prostate cancer risk. The enzyme P450c17α, encoded by the __CYP17__ gene, catalyzes the conversion of progesterone and pregn
## Abstract Fibroblast growth factor receptor 4 (FGFR4) is a member of a family of transmembrane receptors with ligand‐induced tyrosine kinase activity. The Glycine (Gly) to Arginine (Arg) polymorphism at codon 388 (Gly388Arg), which encodes an amino acid in the transmembrane part of the FGFR4 gene